A study led by the Health Research Institute Inclusivethe University Clinical Hospital of Valencia and the Cardiovascular Diseases Area of the Network Biomedical Research Center (CIBERCV) has developed a Innovative model to predict the left ventricular thrombus after an acute myocardial infarction.
In depth
The left ventricular thrombus is a serious and potentially lethal complication that can appear after an acute myocardial infarction. Its precise detection is complex and still nor is defined to which patients make a narrower screening and monitoring.
In this sense, the study published in ‘European Journal of Internal Medicine‘has concluded that it can be predicted if this condition will be developed in the first six months after the infarction carrying out a routine test series prior to hospital discharge.
More details
A total of 590 patients with acute myocardial infarction were evaluated during hospital admission through medical history, electrocardiograms and cardiac ultrasound. Then, a cardiac magnetic resonance was performed to thoroughly analyze the structure and function of the heart.
“The study findings are encouraging: Through routine evaluations during hospital admission, it is possible to assign an individualized risk of developing left ventricular thrombus in the first six months after infarction, “said the doctor Víctor Marcos GarcésCIBERCV researcher cardiologist.
In addition, the classification of patients based on their risk allowed us to know that 20 percent of those included in the highest risk group would develop a left ventricular thrombus.
“This approach would identify more cases early, reducing associated complications and optimizing available resources. In particular, we propose to prioritize Magnetic resonance in those patients with greater risk, achieving a balance between diagnostic efficacy and economic sustainability“He stressed.
To take into account
The conclusions of the study, which have been presented in multiple national and international congresses, open a new perspective in the management of post -infection complications, highlighting the importance of customizing diagnostic resources according to the individual risk of each patient.
This work has had the collaboration of five CIBERCV groups, in addition to the inclusive, in the University Assistance Complex of Salamanca (CAUSE), the Biomedical Research Institute of Salamanca (Ibsal), The University Clinical Hospital of Salamanca and the Clinic and University Hospitals Vall d’Hebron de Barcelona.
#Scientists #discover #innovative #model #predict #left #ventricular #thrombus #acute #myocardial #infarction
